NuCana (NCNA) Net Cash Flow (2017 - 2025)
NuCana (NCNA) reported Net Cash Flow of -$1.3 million for Q4 2025, up 80.07% on a YoY basis from -$745323.1 in Q4 2024, and down 106.0% sequentially from $22.4 million in Q3 2025.
NuCana (NCNA) Net Cash Flow (2017 - 2025) Analysis & Trends
NuCana (NCNA) has 9 years of Net Cash Flow data on file, last reported at -$1.3 million in Q4 2025.
- For the quarter ending Q4 2025, Net Cash Flow rose 80.07% year-over-year to -$1.3 million; the trailing twelve-month figure through Dec 2025 stood at $21.0 million (up 251.98% YoY), and the FY2025 full-year result was $23.3 million, up 268.17% from the prior year.
- Net Cash Flow fell to -$1.3 million in Q4 2025, from $22.4 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $22.4 million in Q3 2025 to a low of -$27.7 million in Q4 2021.
- A 5-year average of -$6.2 million and a median of -$6.9 million in 2024 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow sank 8000.1% in 2024 and jumped 18821.79% in 2025, its largest moves.
- Tracing NCNA's Net Cash Flow over 5 years: stood at -$27.7 million in 2021, then surged by 41.39% to -$16.2 million in 2022, then surged by 99.49% to -$83157.2 in 2023, then slumped by 8000.1% to -$6.7 million in 2024, then jumped by 80.07% to -$1.3 million in 2025.
- Business Quant data shows NCNA's Net Cash Flow at -$1.3 million in Q4 2025, $22.4 million in Q3 2025, and -$6.7 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 60.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.34 Mn |
| Dec 31, 2025 | -1.34 Mn |
| Sep 30, 2025 | 22.37 Mn |
| Sep 30, 2025 | 22.37 Mn |
| Dec 31, 2024 | -6.74 Mn |
| Dec 31, 2024 | -6.74 Mn |
| Sep 30, 2024 | 118,236.32 |
| Sep 30, 2024 | 118,236.32 |
| Jun 30, 2024 | -1.57 Mn |
| Jun 30, 2024 | -1.57 Mn |
| Mar 31, 2024 | -5.65 Mn |
| Mar 31, 2024 | -5.65 Mn |
| Dec 31, 2023 | -83,157.18 |
| Dec 31, 2023 | -83,157.18 |
| Sep 30, 2023 | -9.45 Mn |
| Sep 30, 2023 | -9.45 Mn |
| Jun 30, 2023 | -7.33 Mn |
| Jun 30, 2023 | -7.33 Mn |
| Mar 31, 2023 | -12.41 Mn |
| Mar 31, 2023 | -12.41 Mn |